Skip to main content

Introduction

  • Chapter
  • First Online:

Abstract

This chapter outlines the definition, causes, implications, classifications, epidemiology, economy and perspectives of DFS. The intention is to open up a holistic view of the disease, the people suffering from it and its importance for society.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Armstrong DG, Mills JL. Toward a change in syntax in diabetic foot care: prevention equals remission. J Am Podiatr Med Assoc. 2013;103(2):161–2.

    Article  PubMed  Google Scholar 

  2. Risse A. Phänomenologische und psychopathologische Aspekte in der Diabetologie. Berlin: Walter de Gruyter; 1997.

    Google Scholar 

  3. Armstrong DG, Lavery LA, Holtz-Neiderer K, Mohler MJ, Wendel CS, Nixon BP, Boulton AJ. Variability in activity may precede diabetic foot ulceration. Diabetes Care. 2004;27(8):1980–4.

    Article  PubMed  Google Scholar 

  4. Rosen RC, Davids MS, Bohanske LM, Lemont H. Hemorrhage into plantar callus and diabetes mellitus. Cutis. 1985;35(4):339–41.

    PubMed  CAS  Google Scholar 

  5. Busch K, Chantelau E. Effectiveness of a new brand of stock ‘diabetic’ shoes to protect against diabetic foot ulcer relapse. A prospective cohort study. Diabet Med. 2003;20(8):665–9.

    Article  CAS  PubMed  Google Scholar 

  6. Armstrong DG, Ingelfinger JR, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–75. https://doi.org/10.1056/NEJMra1615439.

    Article  PubMed  Google Scholar 

  7. Chantelau E. Alternativen zur Fußamputation bei diabetischer Podopathie. Was ist gesichert? Dtsch Arztebl. 2002;99(30):A2052–6.

    Google Scholar 

  8. Plank J, Haas W, Rakovac I, Gorzer E, Sommer R, Siebenhofer A, Pieber TR. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care. 2003;26(6):1691–5.

    Article  PubMed  Google Scholar 

  9. Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123–9. https://doi.org/10.2337/dc11-0844.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tanudjaja T, Chantelau E. Recurrent diabetic foot lesions—a study of disease activity in high risc patients. In: The diabetic foot, second international symposium Noordwijkerhout 1995; 1995.

    Google Scholar 

  11. Waaijman R, de Haart M, Arts ML, Wever D, Verlouw AJ, Nollet F, Bus SA. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care. 2014. https://doi.org/10.2337/dc13-2470.

  12. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64–122.

    Article  PubMed  Google Scholar 

  13. Wagner FW Jr. The diabetic foot. Orthopedics. 1987;10(1):163–72.

    PubMed  Google Scholar 

  14. Armstrong DG. The University of Texas diabetic foot classification system. Ostomy Wound Manage. 1996;42(8):60–1.

    PubMed  CAS  Google Scholar 

  15. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21(5):855–9.

    Article  CAS  PubMed  Google Scholar 

  16. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004;20(Suppl 1):S90–5. https://doi.org/10.1002/dmrr.464.

    Article  PubMed  Google Scholar 

  17. Arlt B, Protze J. [Diabetic foot]. Langenbecks Arch Chir Suppl Kongressbd. 1997;114:528–32.

    Google Scholar 

  18. Ince P, Abbas ZG, Lutale JK, Basit A, Ali SM, Chohan F, Morbach S, Mollenberg J, Game FL, Jeffcoate WJ. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care. 2008;31(5):964–7. https://doi.org/10.2337/dc07-2367.

    Article  PubMed  Google Scholar 

  19. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49. https://doi.org/10.1016/j.diabres.2013.11.002.

    Article  PubMed  CAS  Google Scholar 

  20. IDF. IDF diabetes Atlas eight edition 2017. 2017. http://www.diabetesatlas.org. Accessed 18 Feb 2018.

  21. LeMaster JW, Reiber GE, Rayman A. Epidemiology and economic impact of foot ulcers. In: Boulton AJ, Cavenagh PR, Rayman A, editors. The foot in diabetes. 4th ed. Chichester: Wiley; 2006.

    Google Scholar 

  22. Hochlenert D. Qualitätsbericht Netzwerk Diabetischer Fuß Köln und Umgebung 2006; 2007.

    Google Scholar 

  23. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176(2A Suppl):5S–10S.

    Article  CAS  PubMed  Google Scholar 

  24. Hochlenert D. Qualitätsbericht der Netzwerke Diabetischer Fuß Nordrhein, Hamburg und Berlin. 2017. http://www.fussnetz-koeln.de/Start/Dokus/Qualitaetsbericht_2017.pdf.

  25. NHS. National Diabetes Foot Care Audit—2014-2016. 2017. https://www.digital.nhs.uk/catalogue/PUB23525. Accessed 23 Mar 2018.

  26. Apelqvist J. The diabetic foot syndrome today: a pandemic uprise. In: Piaggesi A, Apelqvist J, editors. The diabetic foot syndrome (frontiers in diabetes). Basel: S. Karger AG; 2018.

    Google Scholar 

  27. Kroger K, Berg C, Santosa F, Malyar N, Reinecke H. Lower limb amputation in Germany. Dtsch Arztebl Int. 2017;114(7):130–6. https://doi.org/10.3238/arztebl.2017.0130.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lombardo FL, Maggini M, De Bellis A, Seghieri G, Anichini R. Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010. PLoS One. 2014;9(1):e86405. https://doi.org/10.1371/journal.pone.0086405.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Rumenapf G, Morbach S. Amputation statistics-how to interpret them? Dtsch Arztebl Int. 2017;114(8):128–9. https://doi.org/10.3238/arztebl.2017.0128.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Pickwell KM, Siersma VD, Kars M, Holstein PE, Schaper NC, Consortium on behalf of the Eurodiale. Diabetic foot disease: impact of ulcer location on ulcer healing. Diabetes Metab Res Rev. 2013;29(5):377–83. https://doi.org/10.1002/dmrr.2400.

    Article  PubMed  Google Scholar 

  31. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233(6):485–91.

    Article  CAS  PubMed  Google Scholar 

  32. Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, et al. Importance of factors determining the low health-related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study. Diabet Med. 2013. https://doi.org/10.1111/dme.12254.

  33. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747–55. https://doi.org/10.1007/s00125-008-0940-0.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Icks A, Scheer M, Morbach S, Genz J, Haastert B, Giani G, Glaeske G, Hoffmann F. Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany. Diabetes Care. 2011;34(6):1350–4. https://doi.org/10.2337/dc10-2341.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Chammas NK, Hill RL, Edmonds ME. Increased mortality in diabetic foot ulcer patients: the significance of ulcer type. J Diabetes Res. 2016;2016:2879809. https://doi.org/10.1155/2016/2879809.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Young MJ, McCardle JE, Randall LE, Barclay JI. Improved survival of diabetic foot ulcer patients 1995-2008: possible impact of aggressive cardiovascular risk management. Diabetes Care. 2008;31(11):2143–7. https://doi.org/10.2337/dc08-1242.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Game F. Choosing life or limb. Improving survival in the multi-complex diabetic foot patient. Diabetes Metab Res Rev. 2012;28(Suppl 1):97–100. https://doi.org/10.1002/dmrr.2244.

    Article  PubMed  Google Scholar 

  38. Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, Holstein P, et al. Minor amputation does not negatively affect health-related quality of life as compared with conservative treatment in patients with a diabetic foot ulcer: an observational study. Diabetes Metab Res Rev. 2017;33(3). https://doi.org/10.1002/dmrr.2867.

  39. Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, et al. Health-related quality of life predicts major amputation and death, but not healing, in people with diabetes presenting with foot ulcers: the Eurodiale study. Diabetes Care. 2014;37(3):694–700. https://doi.org/10.2337/dc13-1212.

    Article  PubMed  Google Scholar 

  40. Kerr M. Improving footcare for people with diabetes and saving money: an economic study in England. Insight Health Economics. 2017. https://diabetes-resources-production.s3-eu-west-1.amazonaws.com/diabetes-storage/migration/pdf/Improving%2520footcare%2520economic%2520study%2520%28January%25202017%29.pdf. Accessed 17 Mar 2018.

  41. Hauner H. [Epidemiology and costs of diabetes mellitus in Germany]. Dtsch Med Wochenschr. 2005;130 Suppl 2:S64–65. https://doi.org/10.1055/s-2005-870872.

  42. Koster I, Huppertz E, Hauner H, Schubert I. Direct costs of diabetes mellitus in Germany—CoDiM 2000-2007. Exp Clin Endocrinol Diabetes. 2011;119(6):377–85. https://doi.org/10.1055/s-0030-1269847.

    Article  PubMed  CAS  Google Scholar 

  43. Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826–34. https://doi.org/10.1007/s00125-008-1089-6.

    Article  PubMed  CAS  Google Scholar 

  44. Bakker K, Dooren J. [A specialized outpatient foot clinic for diabetic patients decreases the number of amputations and is cost saving]. Ned Tijdschr Geneeskd. 1994;138(11):565–9.

    Google Scholar 

  45. Hochlenert D. Gesundheitspreis NRW 2012: Netzwerk Diabetischer Fuß Nordrhein (ID-Nr.: 236671). 2012. http://www.mgepa.nrw.de/mediapool/pdf/gesundheit/gesundheitspreis_2012/Sonderpreis_Netzwerk_Diabetischer_Fu___Nordrhein.pdf.

  46. Schaper NC. Lessons from Eurodiale. Diabetes Metab Res Rev. 2012;28(Suppl 1):21–6. https://doi.org/10.1002/dmrr.2266.

    Article  PubMed  Google Scholar 

  47. Sanders LJ, Robbins JM, Edmonds ME. History of the team approach to amputation prevention: pioneers and milestones. J Vasc Surg. 2010;52(3 Suppl):3S–16S. https://doi.org/10.1016/j.jvs.2010.06.002.

    Article  PubMed  Google Scholar 

  48. Kersken J, Gröne C, Lobmann R, Müller E. Die Fußbehandlungseinrichtung der Deutschen Diabetes-Gesellschaft. Diabetologe. 2009;5(2):111–20. https://doi.org/10.1007/s11428-008-0348-y.

    Article  Google Scholar 

  49. Lobmann R, Müller E, Kersken J, Bergmann K, Brunk-Loch S, Gröne C, Lindloh C, Mertens B, Spraul M. The diabetic foot in Germany: analysis of quality in specialised diabetic footcare centres. Diabetic Foot J. 2007;10(2):68–72.

    Google Scholar 

  50. Morbach S, Kersken J, Lobmann R, Nobels F, Doggen K, Van Acker K. The German and Belgian accreditation models for diabetic foot services. Diabetes Metab Res Rev. 2016;32(Suppl 1):318–25. https://doi.org/10.1002/dmrr.2752.

    Article  PubMed  Google Scholar 

  51. Hochlenert D, Engels G. Low major amputation rate and low recurrence in networks for treatment of the DFS. In: Abstract Book, X. Diabetic Foot Study Group Meeting Seminaris See Hotel, Berlin-Potsdam, Germany 28–30 Sept 2012; 2012.

    Google Scholar 

  52. Risse A, Hochlenert D. Integrierte Versorgung—Neue (?) Versorgungsformen am Beispiel des diabetischen Fußsyndroms. Diabetologe. 2010;2:100–7. https://doi.org/10.1007/s11428-009-0480-3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hochlenert, D., Engels, G., Morbach, S., Schliwa, S., Game, F.L. (2018). Introduction. In: Diabetic Foot Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-92055-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92055-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92054-2

  • Online ISBN: 978-3-319-92055-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics